EyePoint Pharmaceuticals Inc. buy Robert W. Baird
Start price
08.05.24
/
50%
€10.75
Target price
08.05.25
€35.34
Performance (%)
-48.52%
End price
09.05.25
€5.53
Summary
This prediction ended on 09.05.25 with a price of €5.53. The BUY prediction by Robert_W__Baird for EyePoint Pharmaceuticals Inc. performed very badly with a performance of -48.52%. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 7.851% | 7.851% | 73.353% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Robert_W__Baird for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Robert W. Baird from $46.00 to $38.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Robert_W__Baird for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.87
11.11.24
11.11.24
€30.99
11.11.25
11.11.25
-8.27%
12.11.25
12.11.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.40
20.04.23
20.04.23
-
20.04.24
20.04.24
205.00%
21.04.24
21.04.24